Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs

Autor Kip, Anke E., Schellens, Jan H. M., Beijnen, Jos H., Dorlo, Thomas P. C.
Vydáno v Clin Pharmacokinet (2017)

Systematic Review of Biomarkers To Monitor Therapeutic Response in Leishmaniasis

Autor Kip, Anke E., Balasegaram, Manica, Beijnen, Jos H., Schellens, Jan H. M., de Vries, Peter J., Dorlo, Thomas P. C.
Vydáno v Antimicrob Agents Chemother (2014)

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis

Autor Castro, María del Mar, Gomez, Maria Adelaida, Kip, Anke E., Cossio, Alexandra, Ortiz, Eduardo, Navas, Adriana, Dorlo, Thomas P. C., Saravia, Nancy Gore
Vydáno v Antimicrob Agents Chemother (2017)

Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa

Autor Palić, Semra, Kip, Anke E, Beijnen, Jos H, Mbui, Jane, Musa, Ahmed, Solomos, Alexandra, Wasunna, Monique, Olobo, Joseph, Alves, Fabiana, Dorlo, Thomas P C
Vydáno v J Antimicrob Chemother (2020)

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis

Autor Kip, Anke E., Wasunna, Monique, Alves, Fabiana, Schellens, Jan H. M., Beijnen, Jos H., Musa, Ahmed M., Khalil, Eltahir A. G., Dorlo, Thomas P. C.
Vydáno v Front Cell Infect Microbiol (2018)

Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure–respo...

Autor Kip, Anke E, Castro, María del Mar, Gomez, Maria Adelaida, Cossio, Alexandra, Schellens, Jan H M, Beijnen, Jos H, Saravia, Nancy Gore, Dorlo, Thomas P C
Vydáno v J Antimicrob Chemother (2018)

Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study

Autor Kip, Anke E, Blesson, Séverine, Alves, Fabiana, Wasunna, Monique, Kimutai, Robert, Menza, Peninah, Mengesha, Bewketu, Beijnen, Jos H, Hailu, Asrat, Diro, Ermias, Dorlo, Thomas P C
Vydáno v J Antimicrob Chemother (2021)

Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinica...

Autor Mbui, Jane, Olobo, Joseph, Omollo, Raymond, Solomos, Alexandra, Kip, Anke E, Kirigi, George, Sagaki, Patrick, Kimutai, Robert, Were, Lilian, Omollo, Truphosa, Egondi, Thaddaeus W, Wasunna, Monique, Alvar, Jorge, Dorlo, Thomas P C, Alves, Fabiana
Vydáno v Clin Infect Dis (2019)

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study

Autor Dorlo, Thomas P C, Kip, Anke E, Younis, Brima M, Ellis, Sally J, Alves, Fabiana, Beijnen, Jos. H, Njenga, Simon, Kirigi, George, Hailu, Asrat, Olobo, Joseph, Musa, Ahmed M, Balasegaram, Manica, Wasunna, Monique, Karlsson, Mats O, Khalil, Eltahir A G
Vydáno v J Antimicrob Chemother (2017)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

Autor Wasunna, Monique, Njenga, Simon, Balasegaram, Manica, Alexander, Neal, Omollo, Raymond, Edwards, Tansy, Dorlo, Thomas P. C., Musa, Brima, Ali, Mohammed Hassan Sharaf, Elamin, Mohammed Yasein, Kirigi, George, Juma, Rashid, Kip, Anke E., Schoone, Gerard J., Hailu, Asrat, Olobo, Joseph, Ellis, Sally, Kimutai, Robert, Wells, Susan, Khalil, Eltahir Awad Gasim, Strub Wourgaft, Nathalie, Alves, Fabiana, Musa, Ahmed
Vydáno v PLoS Negl Trop Dis (2016)